Helsinn differs from other pharmaceutical companies through its implementation of an innovative business approach through Multiproject Integrated Licensing.
Helsinn pinpoints in-licensing candidates at an early clinical stage, acquires their rights, completes their development and transforms them into valuable pharmaceutical products to the highest quality and safety standards and in compliance with FDA and EU requirements, ready for worldwide distribution through Helsinn’s established network of international distributors.
Helsinn provides a complete package of services in support of its products and partners, including continuous scientific development as well as marketing, activities, medical, legal and financial support. |
